← Back to Search

Barrier Method

Test Product for Contraception

N/A

Waitlist Available

Led By Terri Walsh, MPH

Research Sponsored by Church & Dwight Company, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up throughout the study. each participating couple will engage in 8 acts over a 4 week period.

Awards & highlights

Study Summary

This trial is testing how well a new synthetic male condom performs compared to a latex one.

Eligible Conditions

Contraception
Sexually Transmitted Infections

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ throughout the study. each participating couple will engage in 8 acts over a 4 week period.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~throughout the study. each participating couple will engage in 8 acts over a 4 week period.

This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the study. each participating couple will engage in 8 acts over a 4 week period. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Total Clinical Failure Rate

Secondary outcome measures

Clinical Breakage Rate

Clinical Complete Slippage Rate

Side effects data

From 2019 Phase 3 trial • 1550 Patients • NCT04051710

Headache

Anaemia

Pyrexia

100%

80%

60%

40%

20%

Study treatment Arm

Group I (Test)

Group II (Reference)

Group III (Placebo)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Test ProductExperimental Treatment1 Intervention

Synthetic Male Condom

Group II: Control ProductActive Control1 Intervention

Latex Male Condom

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Test Product

2022

Completed Phase 3

~3060

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Church & Dwight Company, Inc.Lead Sponsor

26 Previous Clinical Trials

3,006 Total Patients Enrolled

Essential Access HealthOTHER

6 Previous Clinical Trials

2,270 Total Patients Enrolled

3 Trials studying Contraception

950 Patients Enrolled for Contraception

Terri Walsh, MPHPrincipal InvestigatorEssential Access Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new volunteers being recruited for this clinical trial?

"Yes, according to the information on clinicaltrials.gov, this trial is currently in its recruitment phase. The research was initially posted on June 10th 2022 and recently updated on August 10th 2022. 600 patients are needed from 2 separate locations for participation in the study."

Answered by AI

Am I eligible to join this clinical trial?

"Eligible candidates should have a sexually transmitted infection and be between the ages of 18 to 45. In total, 600 participants are being enrolled for this clinical trial."

Answered by AI

Are individuals aged 45 and above being sought for this clinical experiment?

"As stated in the study's requirements, participants should be aged between 18 and 45. Additionally, there are ancillary clinical trials for individuals below 18 years old as well as over 65."

Answered by AI

What is the total sample size of this medical study?

"Affirmative. According to the clinicaltrials.gov database, this medical experiment is actively recruiting participants and was first posted on June 10th 2022 with its most recent update taking place August 10th of that same year. As of now, 600 people are needed from 2 separate sites for participation in the trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Synthetic Male Condom Slippage-Breakage Study

2022. "Synthetic Male Condom Slippage-Breakage Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05370196.